Medtronic's Strategic Shift: A Landmark IPO and Market Response - AD HOC NEWS

Medtronic subsidiary MiniMed prices $560M IPO at $20 per share - MSN

MiniMed expects to close $644M IPO next week ahead of Medtronic split - MassDevice

Medtronic’s MiniMed goes public for $560M - MedTech Dive

Medtronic’s diabetes unit, MiniMed, drops on IPO (MMED:NASDAQ) - Seeking Alpha

Medtronic’s MiniMed raises $560M in IPO priced below range - Modern Healthcare News

IYH, BMY, MDT, BSX: Large Outflows Detected at ETF - Nasdaq

Medtronic Unit Raises $560 Million in US IPO Priced Below Range - Bloomberg.com

Medtronic's diabetes unit MiniMed raises $560 million in US IPO - Reuters

2 Top Healthcare Dividend Stocks to Buy and Hold Forever

Respiratory Disease Testing Market Global Forecast Report 2026-2032: $9.32 Bn Opportunities in Integrating Advanced Diagnostics, Leveraging Partnerships, and Enhancing Supply Resilience

I took 547 stock recommendations from r/ValueInvesting and had AI grade every single one

SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments

Global Neurorehabilitation Market Projected to Reach USD 6.96 Billion by 2035; Growing Neurological Disorder’s Prevalence to Augment Market Expansion Globally – SNS Insider

The Sleeper Stock That Could Surge Before Wall Street Notices

The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic - AOL.com